vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and MARINE PRODUCTS CORP (MPX). Click either name above to swap in a different company.
MARINE PRODUCTS CORP is the larger business by last-quarter revenue ($64.6M vs $38.3M, roughly 1.7× ImmunityBio, Inc.). MARINE PRODUCTS CORP runs the higher net margin — 3.7% vs -161.8%, a 165.5% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 35.0%). MARINE PRODUCTS CORP produced more free cash flow last quarter ($4.1M vs $-71.3M).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
West Marine is an American company based in Fort Lauderdale, Florida, which operates a chain of boating supply and fishing retail stores. The company has 247 retail stores in North America. West Marine also runs Blue Future a non profit organization. West Marine's flagship store is in Fort Lauderdale. Opened on November 11, 2011, the store is the company's largest at over 50,000 square feet.
IBRX vs MPX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $64.6M |
| Net Profit | $-61.9M | $2.4M |
| Gross Margin | 99.0% | 19.6% |
| Operating Margin | -169.0% | 5.8% |
| Net Margin | -161.8% | 3.7% |
| Revenue YoY | 407.0% | 35.0% |
| Net Profit YoY | -4.7% | -44.6% |
| EPS (diluted) | $-0.06 | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $64.6M | ||
| Q3 25 | $32.1M | $53.1M | ||
| Q2 25 | $26.4M | $67.7M | ||
| Q1 25 | $16.5M | $59.0M | ||
| Q4 24 | $7.6M | $47.8M | ||
| Q3 24 | $6.1M | $49.9M | ||
| Q2 24 | — | $69.5M | ||
| Q1 24 | — | $69.3M |
| Q4 25 | $-61.9M | $2.4M | ||
| Q3 25 | $-67.3M | $2.6M | ||
| Q2 25 | $-92.6M | $4.2M | ||
| Q1 25 | $-129.6M | $2.2M | ||
| Q4 24 | $-59.2M | $4.3M | ||
| Q3 24 | $-85.7M | $3.4M | ||
| Q2 24 | — | $5.6M | ||
| Q1 24 | — | $4.6M |
| Q4 25 | 99.0% | 19.6% | ||
| Q3 25 | 99.4% | 19.2% | ||
| Q2 25 | 99.5% | 19.1% | ||
| Q1 25 | 99.6% | 18.6% | ||
| Q4 24 | — | 19.2% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 18.9% | ||
| Q1 24 | — | 20.2% |
| Q4 25 | -169.0% | 5.8% | ||
| Q3 25 | -173.5% | 5.4% | ||
| Q2 25 | -269.8% | 7.1% | ||
| Q1 25 | -390.1% | 4.4% | ||
| Q4 24 | -919.0% | 7.7% | ||
| Q3 24 | -1314.3% | 7.2% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | -161.8% | 3.7% | ||
| Q3 25 | -209.8% | 5.0% | ||
| Q2 25 | -350.3% | 6.1% | ||
| Q1 25 | -784.9% | 3.7% | ||
| Q4 24 | -783.4% | 8.9% | ||
| Q3 24 | -1404.0% | 6.8% | ||
| Q2 24 | — | 8.0% | ||
| Q1 24 | — | 6.6% |
| Q4 25 | $-0.06 | $0.07 | ||
| Q3 25 | $-0.07 | $0.07 | ||
| Q2 25 | $-0.10 | $0.12 | ||
| Q1 25 | $-0.15 | $0.06 | ||
| Q4 24 | $-0.08 | $0.13 | ||
| Q3 24 | $-0.14 | $0.10 | ||
| Q2 24 | — | $0.14 | ||
| Q1 24 | — | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-500.5M | $125.0M |
| Total Assets | $501.9M | $147.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | — | ||
| Q3 25 | $257.8M | — | ||
| Q2 25 | $153.7M | — | ||
| Q1 25 | $61.6M | — | ||
| Q4 24 | $149.8M | — | ||
| Q3 24 | $130.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-500.5M | $125.0M | ||
| Q3 25 | $-524.3M | $126.3M | ||
| Q2 25 | $-570.7M | $127.2M | ||
| Q1 25 | $-591.4M | $126.4M | ||
| Q4 24 | $-489.1M | $129.0M | ||
| Q3 24 | $-745.1M | $128.8M | ||
| Q2 24 | — | $129.3M | ||
| Q1 24 | — | $151.4M |
| Q4 25 | $501.9M | $147.2M | ||
| Q3 25 | $519.0M | $179.5M | ||
| Q2 25 | $402.1M | $173.2M | ||
| Q1 25 | $303.8M | $182.9M | ||
| Q4 24 | $382.9M | $171.2M | ||
| Q3 24 | $364.6M | $176.3M | ||
| Q2 24 | — | $175.7M | ||
| Q1 24 | — | $204.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $4.7M |
| Free Cash FlowOCF − Capex | $-71.3M | $4.1M |
| FCF MarginFCF / Revenue | -186.2% | 6.4% |
| Capex IntensityCapex / Revenue | 2.4% | 0.9% |
| Cash ConversionOCF / Net Profit | — | 2.00× |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | $14.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $4.7M | ||
| Q3 25 | $-68.9M | $2.6M | ||
| Q2 25 | $-79.7M | $-1.6M | ||
| Q1 25 | $-85.9M | $10.8M | ||
| Q4 24 | $-85.1M | $4.6M | ||
| Q3 24 | $-98.8M | $5.1M | ||
| Q2 24 | — | $3.8M | ||
| Q1 24 | — | $15.9M |
| Q4 25 | $-71.3M | $4.1M | ||
| Q3 25 | $-69.6M | $2.1M | ||
| Q2 25 | $-80.8M | $-2.0M | ||
| Q1 25 | $-87.0M | $10.7M | ||
| Q4 24 | $-87.3M | $3.6M | ||
| Q3 24 | $-101.6M | $3.2M | ||
| Q2 24 | — | $3.0M | ||
| Q1 24 | — | $15.0M |
| Q4 25 | -186.2% | 6.4% | ||
| Q3 25 | -217.2% | 4.0% | ||
| Q2 25 | -305.9% | -3.0% | ||
| Q1 25 | -526.9% | 18.1% | ||
| Q4 24 | -1155.4% | 7.6% | ||
| Q3 24 | -1663.2% | 6.5% | ||
| Q2 24 | — | 4.4% | ||
| Q1 24 | — | 21.7% |
| Q4 25 | 2.4% | 0.9% | ||
| Q3 25 | 2.3% | 0.8% | ||
| Q2 25 | 4.1% | 0.6% | ||
| Q1 25 | 6.8% | 0.2% | ||
| Q4 24 | 28.0% | 2.1% | ||
| Q3 24 | 45.7% | 3.8% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | — | 2.00× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | -0.39× | ||
| Q1 25 | — | 4.88× | ||
| Q4 24 | — | 1.09× | ||
| Q3 24 | — | 1.51× | ||
| Q2 24 | — | 0.68× | ||
| Q1 24 | — | 3.46× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IBRX
Segment breakdown not available.
MPX
| Boats And Accessories | $63.4M | 98% |
| Parts | $1.1M | 2% |
